NCT02711566

Brief Summary

Robot-assisted therapy has proven effective in the neuromotor rehabilitation of eg stroke survivors. Robots can be programmed to interact with patients by guiding their movements, by monitoring their performance and by quantifying the type and degree of their impairment. A distinctive element of multiple sclerosis is the involvement of a variety of functional systems, in a way that is highly subject-specific. This requires a personalization of treatment, and continuous adaptation to changes in condition. This points to a need for integrating patient assessment, definition of rehabilitation protocols, their administration and the assessment of their outcome. The goal of this study is to assess, in persons with MS, the efficacy of a type of robot-assisted training that was specifically designed to counteract incoordination and muscle weakness (typical of MS), tailored to individual type and degree of impairment, when compared to simple movement training.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
41

participants targeted

Target at P25-P50 for not_applicable multiple-sclerosis

Timeline
Completed

Started Jan 2010

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2010

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2011

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2011

Completed
4.2 years until next milestone

First Submitted

Initial submission to the registry

February 29, 2016

Completed
17 days until next milestone

First Posted

Study publicly available on registry

March 17, 2016

Completed
Last Updated

March 17, 2016

Status Verified

May 1, 2015

Enrollment Period

1.5 years

First QC Date

February 29, 2016

Last Update Submit

March 11, 2016

Conditions

Keywords

RehabilitationRobot-assisted therapy

Outcome Measures

Primary Outcomes (1)

  • Change of the 9 Hole Peg Test score

    baseline and 4 weeks and baseline and 16 weeks

Secondary Outcomes (3)

  • Treatment change in percentage of responders at 9 Hole Peg Test score

    baseline and 4 weeks and baseline and 16 weeks

  • Absolute change of exercise performance

    baseline and 4 weeks and baseline and 16 weeks

  • Absolute change of task difficulty

    baseline and 4 weeks and baseline and 16 weeks

Study Arms (2)

Sensorimotor training

ACTIVE COMPARATOR

Patients in this arm were assigned to the 'Physioassistant: Haptic training' intervention. The treatments were delivered through a planar robotic manipulandum, specifically designed for motor learning studies and robot-assisted rehabilitation. All participating centers used the exact same apparatus and experimental set-up.

Device: Physioassistant: Sensorimotor training

Haptic training

EXPERIMENTAL

Patients in this arm were assigned to the 'Physioassistant: Sensorimotor training' intervention. The treatments were delivered through a planar robotic manipulandum, specifically designed for motor learning studies and robot-assisted rehabilitation. All participating centers used the exact same apparatus and experimental set-up.

Device: Physioassistant: Haptic training

Interventions

Subjects in the Haptic training arm had to perform fast-and-accurate reaching movements in different directions. reaching was mediated by a virtual 'tool', consisting of a virtual point mass (m=5 kg) connected to the subjects' hand through a linear spring (stiffness range: Km=200-500 N/m). An additional spring (stiffness range: Kr = 20-70 N/m) was connected between hand a starting point to resist movements. Subjects were instructed to move the virtual point mass as fast as possible through suitable hand motions, so that the mass ends up and stops on the 'target' area.

Haptic training

Subjects in the Sensorimotor training arm had to perform fast-and-accurate reaching movements in different directions. The manipulandum was only used to record hand movements, but throughout the movement it generated no forces.

Sensorimotor training

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • definite Multiple sclerosis, stable phase of the disease
  • no relapses or worsening \>1 in the Expanded Disability Status Scale in the last three months,
  • Expanded Disability Status Scale\<7.5,
  • Ashworth score at the upper limb lower than 2,
  • Nine-Hole Peg Test between 30 s and 180 s

You may not qualify if:

  • previous treatment with robot therapy,
  • presence of severe nystagmus,
  • visual acuity less than 4/10
  • major orthopaedic or other disorders interfering with the protocol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Basteris A, De Luca A, Sanguineti V, Solaro C, Mueller M, Carpinella I, Cattaneo D, Bertoni R, Ferrarin M. A tailored exercise of manipulation of virtual tools to treat upper limb impairment in Multiple Sclerosis. IEEE Int Conf Rehabil Robot. 2011;2011:5975509. doi: 10.1109/ICORR.2011.5975509.

    PMID: 22275705BACKGROUND
  • Solaro C, Cattaneo D, Basteris A, Carpinella I, De Luca A, Mueller M, Bertoni R, Ferrarin M, Sanguineti V. Haptic vs sensorimotor training in the treatment of upper limb dysfunction in multiple sclerosis: A multi-center, randomised controlled trial. J Neurol Sci. 2020 May 15;412:116743. doi: 10.1016/j.jns.2020.116743. Epub 2020 Feb 19.

MeSH Terms

Conditions

Multiple Sclerosis

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System Diseases

Study Officials

  • Claudio M Solaro, MD

    ASL 3 Genovese

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 29, 2016

First Posted

March 17, 2016

Study Start

January 1, 2010

Primary Completion

July 1, 2011

Study Completion

December 1, 2011

Last Updated

March 17, 2016

Record last verified: 2015-05